<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>We describe 17 children with nocturnal or early-morning <z:hpo ids='HP_0001250'>seizures</z:hpo> who were switched to a proportionally higher evening dose of <z:chebi fb="0" ids="35623">antiepileptic</z:chebi> drugs and were retrospectively reviewed for <z:hpo ids='HP_0001250'>seizure</z:hpo> outcome and side effects </plain></SENT>
<SENT sid="1" pm="."><plain>Of 10 children with unknown etiology, clinical presentation was consistent with nocturnal <z:e sem="disease" ids="C0085541" disease_type="Disease or Syndrome" abbrv="">frontal lobe epilepsy</z:e> (NFLE) in 5 and benign <z:e sem="disease" ids="C0014544" disease_type="Disease or Syndrome" abbrv="">epilepsy</z:e> with centrotemporal spikes (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BECTS</z:e>) in 3 </plain></SENT>
<SENT sid="2" pm="."><plain>After a mean follow-up of 5.3 months, 15 patients were classified as responders; 11 of these became <z:hpo ids='HP_0001250'>seizure</z:hpo> free (5 NFLE, 1 BECTS, 5 with structural lesions) and 4 (2 BECTS, 2 with structural lesions) experienced 75-90% reductions in <z:hpo ids='HP_0001250'>seizures</z:hpo> </plain></SENT>
<SENT sid="3" pm="."><plain>Among two nonresponders, <z:hpo ids='HP_0001250'>seizures</z:hpo> in one had failed to resolve with <z:e sem="disease" ids="C0014544" disease_type="Disease or Syndrome" abbrv="">epilepsy</z:e> surgery </plain></SENT>
<SENT sid="4" pm="."><plain>Nine subjects (53%) received monotherapy after dose modification, and none presented with worsening of <z:hpo ids='HP_0001250'>seizures</z:hpo> </plain></SENT>
<SENT sid="5" pm="."><plain>Two complained of transient side effects (<z:mp ids='MP_0002899'>fatigue</z:mp>/<z:hpo ids='HP_0001262'>somnolence</z:hpo>) </plain></SENT>
<SENT sid="6" pm="."><plain>Differential dosing led to <z:hpo ids='HP_0001250'>seizure</z:hpo> freedom in 64.7% (11/17) of patients, and 88.2% (15/17) experienced â‰¥ 50% reductions in <z:hpo ids='HP_0001250'>seizures</z:hpo> </plain></SENT>
</text></document>